Daily Bulletin (28th December, 2021)
https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20211228-41
Scrip code : 532331
Name : Ajanta Pharma Ltd.
Subject : Board Meeting Outcome for Approval For Buy-Back Of Shares
Board of Directors of the Company, at its meeting held today, i.e., December 28, 2021, has inter-alia unanimously approved Buy-back of up to 11,20,000 fully paid-up Equity Shares of face value of ? 2/- each by the Company (representing 1.29%of the total number of Equity Shares of the Company) at a price of ? 2,550/- (Rupees Two Thousand Five Hundred and Fifty only) per Equity Share payable in cash for a total consideration not exceeding ? 285.60 crores (Rupees Two Hundred Eighty Five Crores and Sixty Lakhs only) (excluding transaction costs such as fees, brokerage, taxes, duties, etc.), which is not exceeding 10% of the total paid-up equity share capital and free reserves (including securities premium account) as per the audited financial statements of the Company for the financial year ended on March 31, 2021, through the ‘Tender Offer’ route.
Scrip code : 531673
Name : Anka India Ltd.
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Pursuant to Regulation 30 of the SEBI (Listing and Disclosure Obligation) Regulations, 2015, it is hereby informed that Anka India Limited has acquired complete rights of 3 Marathi motion Pictures namely a) ‘Date Bhet’ produced by Candid Films Limited, United Kingdom and directed by Lokesh Gupte in which Sonali Kulkarni and Hemant Dhome are starring. b) ‘Shreemati Umbrella’, produced by Elegant Pictures Limited, United Kingdom and directed by Gajendra Ahire in which Sonali Kulkarni and Mrinal Kulkarni are starring. c) ‘Return Journey’, produced by Intense Films Limited, United Kingdom and directed by Gajendra Ahire in which Abhinay Berde and Ketki Narayan are starring.
Scrip code : 500087
Name : Cipla Ltd.,
Subject : Announcement under Regulation 30 (LODR)-Press Release / Media Release
Cipla receives Emergency Use Authorisation (EUA) to launch oral anti-viral drug Cipmolnu® (Molnupiravir 200 mg) in India to treat mild to moderate COVID-19 at high risk of developing severe disease.
Scrip code : 542851
Name : Gensol Engineering Limited
Subject : GENSOL STEPS UP ITS COMMITMENT INTO THE ELECTRIC VEHICLES (‘EV’) SEGMENT.
Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform that the members of the company have given their nod to a new business initiative in the Electric Vehicle (EV) space during 8th Annual General Meeting held on September 30, 2020. In line with this prognosis, our company has, till date, leased out a total of 181 EV Cars to reputed ride-hailing company operating its business in Gurugram, NCR and New Delhi regions. We plan to add another 67 new EV Cars by the end of December 2021, while massive plans have been firmed up to add another 3000 EV cars to this fleet by the end of 2022. We request you to take the above information on your records and disseminate the same on your respective websites. Further, in this regard, an Investor Release issued by the Company is enclosed herewith for the information of the exchanges. Thanking you.
Scrip code : 526729
Name : Goldiam International Ltd.
Subject : Buyback Of Equity Shares – Completion Of Extinguishment/Destruction Of A Total Of 3,80,000 Equity Shares
Pursuant to the Public Announcement dated October 14, 2021 (the ‘Public Announcement’) and the Letter of Offer dated November 12, 2021 (the ‘Letter of Offer’), the Tendering Period for the Buyback opened on November 26, 2021 and closed on December 9, 2021. Pursuant to Regulation 24 (iv) of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the ‘Buyback Regulations’), the following are the details of the Equity Shares bought back by the Company during the Tendering Period and extinguished/destroyed: Equity share capital before the said extinguishment (Number of Equity Shares) Number of Equity Shares extinguished/ destroyed Equity share capital after the said extinguishment (Number of Equity Shares) 2,21,74,923 3,80,000 2,17,94,923.
Scrip code : 538979
Name : Greenlam Industries Ltd
Subject : Intimation Under Regulation 30 W.R.T. Raising Of Funds By Issuance Of Securities
This is to inform you that in terms of Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held on December 28, 2021, have considered and approved raising of funds and issuance of Equity shares / other financial instruments convertible into equity shares (including warrants) through Qualified Institution Placement (QIP} basis or any other permissible modes (in one or more tranches) for an aggregate amount up to Rs. 500 Crore (Rupees Five Hundred Crore only) including premium, subject to necessary approvals from shareholder/regulators, as applicable. In furtherance to the above, the Board has decided to obtain shareholders” approval through postal ballot for raising of funds and issuance of securities as mentioned above.
Scrip code : 532527
Name : ramkrishna forgings Ltd.
Subject : Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release titled ‘RKFL gets LOI worth USD INR 225 Million per annum from Mexico’.
Scrip code : 532923
Name : RENAISSANCE GLOBAL LIMITED
Subject : Announcement Under Regulation 30 (LODR) – Updates – Incorporation Of Step Down Subsidiaries In USA
In accordance with Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, this is to inform you that the wholly owned subsidiary of the Company in Dubai viz. ‘Verigold Jewellery DMCC’ (VJDMCC) has incorporated a subsidiary and a step down subsidiary in USA namely ‘Renaissance D2C Ventures Inc.’ and ‘Renaissance FMI Inc.’, respectively.
Scrip code : 541163
Name : Sandhar Technologies Limited
Subject : Announcement under Regulation 30 (LODR)-Acquisition
In continuation of the intimation dated 06th December 2021, we wish to inform that Sandhar Technologies Limited (‘the Company’) has acquired/purchased 1,48,23,143 equity shares (i.e. 47.82% of total shareholding) of Sandhar Daewha Automotive Systems Private Limited on 28th December, 2021. The shareholding of the Company has increased from 52.18% to 100% of the total shareholding in Sandhar Daewha Automotive Systems Private Limited (‘SDASPL’), accordingly SDASPL has become the Wholly Owned Subsidiary of the Company. The details as required under SEBI Listing Regulations read with SEBI Circular No. CIR/CFO/CMD/4/2015 dated September 9, 2015 are as attached.
Scrip code : 507894
Name : Schablona India Ltd
Subject : Update – Scheme Of Amalgamation Of Schablona India Limited With Somany Ceramics Limited In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Scheme of Amalgamation of the Company with Somany Ceramics Limited under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder, has been approved by the Hon’ble National Company Law Tribunal, New Delhi, Principal Bench vide order pronounced on 24th December, 2021 and the same was uploaded on the website of NCLT on 27th December, 2021, a copy of which is enclosed. The said Scheme of Amalgamation would be effective from the date of filing of the NCLT order with the concerned Registrar of Companies.
Scrip code : 511218
Name : Shriram Transport Finance Co. Ltd.
Subject : Intimation Of Committee Meetings For Raising Funds
In furtherance to our letter dated October 29, 2021 regarding outcome of Board Meeting we hereby inform that pursuant to regulation 29(2)regulation 50 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the Company will consider raising of funds by way of issue of redeemable nonconvertible debt securities including bonds inonshore/offshore market on privateplacement basis and/or public issue subject to market conditions and in this regard, the meetings of the concerned committees viz. Banking and Finance Committee,Debt Issuance Committee, Bond Issuance Committee and Allotment CommitteeNCDs will be held to consider and approve the issueand allotment of redeemable nonconvertible debt securities/bonds during the month ending January 31, 2022 as per their respective terms of reference subject to such terms and conditions including issue price of debt securities/bonds as the said committees maydeemfit.
Scrip code : 512359
Name : Sword-Edge Commercials Limited
Subject : Reg 42 As Per SEBI LODR Intimation Of Record Date For Issuance Of Bonus Shares In The Proportion Of 1:1 I.E. 1 (One) Equity Shares Of Rs. 1/- Each For Every 1 (One) Existing Equity Share Of Rs. 1/- Each.
In terms of Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has fixed Friday, February 04, 2022 as the “Record Date”, for the purpose of ascertaining the eligibility of shareholders entitled for issuance of Bonus Equity Shares of the Company in the proportion of 1 (One) Equity Shares of Rs. 1/- each for every 1 (One) existing Equity Share of Rs. 1/- each, subject to the approval of shareholders which is being obtained through Postal Ballot (including e-voting) in accordance with the applicable laws and regulations thereby ensuring the compliance with the requirement of 5 working days gap between declaration of results of postal ballot and record date. The above information will also be made available on the website of the Company: www.swordedgecommercialsltd.in You are requested to take the above information on record. Thanking You.
Scrip code : 500420
Name : Torrent Pharmaceuticals Ltd.
Subject : Clarification sought from Torrent Pharmaceuticals Ltd
The Exchange has sought clarification from Torrent Pharmaceuticals Ltd with respect to news article appearing on https://www.moneycontrol.com/ December 27, 2021 titled “Torrent Pharma recalls over 27,000 bottles of blood pressure lowering drug in US”. The reply is awaited.
